Work

A First in Human Study Planned to Evaluate Hdp-101, an Anti-BCMA Amanitin Antibody-Drug Conjugate with a New Payload and a New Mode of Action, in Multiple Myeloma

Year: 2020

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2020-142285

Authors: Andras Strassz, Marc S. Raab, Robert Z. Orlowski, Michael Kulke, Gudrun Schiedner, Andreas Pahl

Institutions: Heidelberg Pharma (Germany), German Cancer Research Center, University Hospital Heidelberg, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3095331110

Cites:

Cited by: 16

Related to: 10